LORECa vs Cleverear Uso & Estadísticas

LORECa is a Turkish hearing aid company, established in 1996, known for producing CE-labeled digital and analog hearing aids. They offer various models, including ITE, ITC, CIC, and BTE. With a focus on R&D, LORECa aims to enhance the quality of life for those with hearing impairments through innovative and high-quality products. LORECa is a hearing aid company based in Turkey, known for being the sole manufacturer of CE-labeled hearing instruments in the country. The company, which began in 1996, focuses on developing, producing, and distributing both digital and analog hearing aids. LORECa is certified with EN ISO 9001:2000 and EN ISO 13485:2003, ensuring high-quality products. LORECa's product range includes custom in-the-ear (ITE), in-the-canal (ITC), completely-in-canal (CIC), and behind-the-ear (BTE) hearing aids. The company invests heavily in research and development, particularly in hearing aid chips and algorithms, to provide innovative solutions for people with hearing loss. They also offer a range of wireless and non-wireless digital signal processor (DSP) systems for hearing aids. Their mission is to improve the quality of life for individuals with hearing impairments through advanced technology and high-quality hearing aid products.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

Cleverear allows you to adjust audio, aux, mic, stream channel settings via a bluetooth connection for hearing aids.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

LORECa frente a Cleverear: comparación de la clasificación

Comparar la tendencia de clasificación de LORECa en los últimos 28 días con Cleverear

Rank

No hay datos disponibles

Comparación de las clasificaciones LORECa frente a Cleverear por países

Comparar la tendencia de clasificación de LORECa en los últimos 28 días con Cleverear

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
LORECa VS.
Cleverear

enero 5, 2025